GSK plc Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2010-12-20: Form 6-K; Period of report 2010-12-20; Description DIRECTOR/PDMR SHAREHOLDING; Document gsk201012206k.htm.
- 2010-12-14: Form 6-K; Period of report 2010-12-13; Description GSK TO ACQUIRE MAXINUTRITION; Document gsk201012136k.htm.
- 2010-12-13: Form 6-K; Period of report 2010-12-10; Description DIRECTOR/PDMR SHAREHOLDING; Document gsk201012106k.htm.
- 2010-12-10: Form 6-K; Period of report 2010-12-10; Description DIRECTOR/PDMR SHAREHOLDING; Document gsk201012106k.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2010-12-20 | 6-K | 2010-12-20 | DIRECTOR/PDMR SHAREHOLDING | gsk201012206k.htm |
| 2010-12-14 | 6-K | 2010-12-13 | GSK TO ACQUIRE MAXINUTRITION | gsk201012136k.htm |
| 2010-12-13 | 6-K | 2010-12-10 | DIRECTOR/PDMR SHAREHOLDING | gsk201012106k.htm |
| 2010-12-10 | 6-K | 2010-12-10 | DIRECTOR/PDMR SHAREHOLDING | gsk201012106k.htm |
| 2010-12-07 | 6-K | 2010-12-07 | GSK TO ACQUIRE NANJING MEIRUI PHARMACEUTICALS | gsk201012076k.htm |
| 2010-12-01 | 6-K | 2010-12-01 | TOTAL VOTING RIGHTS | gsk201012016k.htm |
| 2010-11-29 | 6-K | 2010-11-29 | GSK TO INCREASE ITS SHAREHOLDING IN THERAVANCE | gsk201011296k.htm |
| 2010-11-12 | 6-K | 2010-11-12 | BLOCKLISTING INTERIM REVIEW | gsk201011126k.htm |
| 2010-11-10 | 6-K | 2010-11-10 | DIRECTOR/PDMR SHAREHOLDING | gsk201011106k.htm |
| 2010-11-08 | 6-K | 2010-11-08 | DIRECTOR/PDMR SHAREHOLDING | gsk201011086k.htm |
| 2010-11-03 | 6-K | 2010-11-03 | DIRECTOR/PDMR SHAREHOLDING | gsk201011036k.htm |
| 2010-11-01 | 6-K | 2010-11-01 | TOTAL VOTING RIGHTS | gsk201011016k.htm |
| 2010-10-21 | 6-K | 2010-10-21 | FORM 6-K | u09964e6vk.htm |
| 2010-10-14 | 6-K | 2010-10-14 | DIRECTOR/PDMR SHAREHOLDING | gsk201010146k.htm |
| 2010-10-13 | 6-K | 2010-10-13 | DIRECTOR/PDMR SHAREHOLDING | gsk201010136k4.htm |
| 2010-10-13 | 6-K | 2010-10-13 | DIRECTOR/PDMR SHAREHOLDING | gsk201010136k3.htm |
| 2010-10-13 | 6-K | 2010-10-13 | DIRECTOR/PDMR SHAREHOLDING | gsk201010136k2.htm |
| 2010-10-13 | 6-K | 2010-10-13 | DIRECTOR/PDMR SHAREHOLDING | gsk201010136k.htm |
| 2010-10-12 | 6-K | 2010-10-12 | DIRECTOR/PDMR SHAREHOLDING | gsk201010126k3.htm |
| 2010-10-12 | 6-K | 2010-10-12 | DIRECTOR/PDMR SHAREHOLDING | gsk201010126k2.htm |
| 2010-10-12 | 6-K | 2010-10-12 | DIRECTOR/PDMR SHAREHOLDING | gsk201010126k.htm |
| 2010-10-12 | 6-K | 2010-10-11 | DIRECTOR/PDMR SHAREHOLDING | gsk201010116k.htm |
| 2010-10-08 | 6-K | 2010-10-08 | DIRECTOR/PDMR SHAREHOLDING | gsk201010086k2.htm |
| 2010-10-08 | 6-K | 2010-10-08 | DIRECTOR/PDMR SHAREHOLDING | gsk201010086k.htm |
| 2010-10-04 | 6-K | 2010-10-04 | GSK TAKES STAKE IN CONVERGENCE PHARMACEUTICALS | gsk201010046k3.htm |
| 2010-10-01 | 6-K | 2010-10-01 | DIRECTOR/PDMR SHAREHOLDING | gsk201010016k2.htm |
| 2010-10-01 | 6-K | 2010-10-01 | TOTAL VOTINGS RIGHT | gsk201010016k.htm |
| 2010-09-23 | 6-K | 2010-09-23 | GSK REGULATORY UPDATE ON AVANDIA | gsk201009236k.htm |
| 2010-09-10 | 6-K | 2010-09-10 | DIRECTOR/PDMR SHAREHOLDING | gsk201009106k3.htm |
| 2010-09-10 | 6-K | 2010-09-10 | NOTIFICATION PURSUANT TO LISTING RULE 9.6.13 | gsk201009106k2.htm |
| 2010-09-10 | 6-K | 2010-09-10 | GSK HISTORICAL QUARTERLY TURNOVER BY PRODUCT | gsk201009106k.htm |
| 2010-09-08 | 6-K | 2010-09-08 | DIRECTORATE CHANGE | gsk201009086k.htm |
| 2010-09-01 | 6-K | 2010-09-01 | TOTAL VOTING RIGHTS | gsk201009016k.htm |
| 2010-08-25 | 6-K | 2010-08-25 | DIRECTOR/PDMR SHAREHOLDING | gsk201008256k.htm |
| 2010-08-18 | 6-K | 2010-08-18 | HOLDING(S) IN COMPANY | gsk201008186k.htm |
| 2010-08-11 | 6-K | 2010-08-11 | DIRECTOR/PDMR SHAREHOLDING | gsk201008116k.htm |
| 2010-08-10 | 6-K | 2010-08-10 | DIRECTOR/PDMR SHAREHOLDING | gsk201008106k.htm |
| 2010-08-09 | 6-K | 2010-08-09 | DIRECTOR/PDMR SHAREHOLDING | gsk201008096k.htm |
| 2010-08-05 | 6-K | 2010-08-05 | DIRECTOR/PDMR SHAREHOLDING | gsk201008056k2.htm |
| 2010-08-05 | 6-K | 2010-08-05 | DIRECTOR/PDMR SHAREHOLDING | gsk201008056k3.htm |
| 2010-08-05 | 6-K | 2010-08-05 | DIRECTOR/PDMR SHAREHOLDING | gsk201008056k.htm |
| 2010-08-04 | 6-K | 2010-08-04 | HOLDING(S) IN COMPANY | gsk201008046k.htm |
| 2010-08-03 | 6-K | 2010-08-03 | HOLDING(S) IN COMPANY | gsk201008036k.htm |
| 2010-08-02 | 6-K | 2010-08-02 | DIRECTOR/PDMR SHAREHOLDING | gsk201008026k2.htm |
| 2010-08-02 | 6-K | 2010-08-02 | TOTAL VOTING RIGHTS | gsk201008026k.htm |
| 2010-07-27 | 6-K/A | 2010-07-27 | DIRECTOR/PDMR SHAREHOLDING | gsk201007276ka.htm |
| 2010-07-23 | 6-K/A | 2010-07-23 | DIRECTOR/PDMR SHAREHOLDING | gsk201007236ka.htm |
| 2010-07-21 | 6-K | 2010-07-21 | FORM 6-K | u09419e6vk.htm |
| 2010-07-15 | 6-K | 2010-07-15 | GSK LEGAL UPDATE | gsk201007156k.htm |
| 2010-07-15 | 6-K | 2010-07-14 | RESPONSE TO FDA ADVISORY COMMITTEES' AVANDIA VOTE | gsk201007146k2.htm |
| 2010-07-14 | 6-K | 2010-07-14 | DIRECTOR/PDMR SHAREHOLDING | gsk201007146k.htm |
| 2010-07-13 | 6-K | 2010-07-13 | DIRECTOR/PDMR SHAREHOLDING | gsk201007136k3.htm |
| 2010-07-13 | 6-K | 2010-07-13 | DIRECTOR/PDMR SHAREHOLDING | gsk201007136k2.htm |
| 2010-07-13 | 6-K | 2010-07-13 | DIRECTOR/PDMR SHAREHOLDING | gsk201007136k5.htm |
| 2010-07-13 | 6-K | 2010-07-13 | DIRECTOR/PDMR SHAREHOLDING | gsk201007136k4.htm |
| 2010-07-13 | 6-K | 2010-07-13 | DIRECTOR/PDMR SHAREHOLDING | gsk201007136k.htm |
| 2010-07-12 | 6-K | 2010-07-12 | DIRECTOR/PDMR SHAREHOLDING | gsk201007126k3.htm |
| 2010-07-12 | 6-K | 2010-07-12 | DIRECTOR/PDMR SHAREHOLDING | gsk201007126k2.htm |
| 2010-07-12 | 6-K | 2010-07-12 | DIRECTOR/PDMR SHAREHOLDING | gsk201007126k.htm |
| 2010-07-07 | 6-K | 2010-07-07 | DIRECTOR/PDMR SHAREHOLDING | gsk201007076k.htm |
| 2010-07-02 | 6-K | 2010-07-02 | CHANGE OF ANNOUNCEMENT DATE | gsk201007026k.htm |
| 2010-07-01 | 6-K | 2010-07-01 | TOTAL VOTING RIGHTS | gsk201007016k.htm |
| 2010-07-01 | 6-K | 2010-07-01 | DIRECTOR/PDMR SHAREHOLDING | gsk201007016k2.htm |
| 2010-06-10 | 6-K | 2010-06-10 | DIRECTOR/PDMR SHAREHOLDING | gsk201006106k2.htm |
| 2010-06-10 | 6-K | 2010-06-10 | GSK DRIVES LATIN AMERICA GROWTH STRATEGY | gsk201006106k.htm |
| 2010-06-01 | 6-K | 2010-06-01 | TOTAL VOTING RIGHTS | gsk201006016k.htm |
| 2010-05-13 | 6-K | 2010-05-13 | DIRECTOR/PDMR SHAREHOLDING | gsk201005136k.htm |
| 2010-05-11 | 6-K | 2010-05-11 | GSK NEW STRATEGIC ALLIANCE IN SOUTH KOREA | gsk201005116k.htm |
| 2010-05-10 | 6-K | 2010-05-10 | BLOCKLISTING INTERIM REVIEW | gsk201005106k.htm |
| 2010-05-07 | 6-K | 2010-05-07 | DIRECTOR/PDMR SHAREHOLDING | gsk201005076k2.htm |
| 2010-05-07 | 6-K | 2010-05-07 | DIRECTOR/PDMR SHAREHOLDING | gsk201005076k.htm |
| 2010-05-06 | 6-K | 2010-05-06 | AGM STATEMENT | gsk201005066k.htm |
| 2010-05-04 | 6-K | 2010-05-04 | DIRECTOR/PDMR SHAREHOLDING | gsk201005046k2.htm |
| 2010-05-04 | 6-K | 2010-05-04 | TOTAL VOTING RIGHTS | gsk201005046k.htm |
| 2010-04-28 | 6-K | 2010-04-28 | 6-K | u08854e6vk.htm |
| 2010-04-21 | 6-K | 2010-04-21 | DIRECTOR/PDMR SHAREHOLDING | gsk201004216k.htm |
| 2010-04-19 | 6-K | 2010-04-19 | DIRECTOR/PDMR SHAREHOLDING | gsk201004196k.htm |
| 2010-04-16 | 6-K | 2010-04-16 | DIRECTOR/PDMR SHAREHOLDING | gsk201004166k.htm |
| 2010-04-15 | 6-K | 2010-04-15 | DIRECTOR/PDMR SHAREHOLDING | gsk201004156k.htm |
| 2010-04-14 | 6-K | 2010-04-14 | DIRECTOR/PDMR SHAREHOLDING | gsk201004146k4.htm |
| 2010-04-14 | 6-K | 2010-04-14 | DIRECTOR/PDMR SHAREHOLDING | gsk201004146k3.htm |
| 2010-04-14 | 6-K | 2010-04-14 | DIRECTOR/PDMR SHAREHOLDING | gsk201004146k2.htm |
| 2010-04-14 | 6-K | 2010-04-14 | DIRECTOR/PDMR SHAREHOLDING | gsk201004146k.htm |
| 2010-04-13 | 6-K | 2010-04-13 | DIRECTOR/PDMR SHAREHOLDING | gsk201004136k2.htm |
| 2010-04-13 | 6-K | 2010-04-13 | DIRECTOR/PDMR SHAREHOLDING | gsk201004136k.htm |
| 2010-04-12 | 6-K | 2010-04-12 | DIRECTOR/PDMR SHAREHOLDING | gsk201004126k.htm |
| 2010-04-07 | 6-K | 2010-04-07 | DIRECTOR/PDMR SHAREHOLDING | gsk201004076k2.htm |
| 2010-04-07 | 6-K | 2010-04-07 | DIRECTOR/PDMR SHAREHOLDING | gsk201004076k.htm |
| 2010-04-01 | 6-K | 2010-04-01 | TOTAL VOTING RIGHTS | gsk201004016k2.htm |
| 2010-04-01 | 6-K | 2010-04-01 | DIRECTOR/PDMR SHAREHOLDING | gsk201004016k.htm |
| 2010-03-29 | 6-K | 2010-03-29 | NOTIFIABLE SHARE INTEREST IN JCR PHARMACEUTICALS | gsk201003296k.htm |
| 2010-03-26 | 6-K | 2010-03-26 | CHANGE TO BOARD COMMITTEE | gsk201003266k2.htm |
| 2010-03-26 | 6-K | 2010-03-26 | NOTIFIABLE SHARE INTEREST IN JCR PHARMACEUTICALS | gsk201003266k.htm |
| 2010-03-25 | 6-K | 2010-03-25 | ANNUAL INFORMATION UPDATE | gsk201003256k.htm |
| 2010-03-22 | 6-K | 2010-03-22 | DIRECTOR/PDMR SHAREHOLDING | gsk201003226k2.htm |
| 2010-03-22 | 6-K | 2010-03-22 | NOTIFIABLE SHARE INTEREST IN OCTOPLUS N.V. | gsk201003226k.htm |
| 2010-03-16 | 6-K | 2010-03-16 | DIRECTOR/PDMR SHAREHOLDING | gsk201003166k2.htm |
| 2010-03-16 | 6-K | 2010-03-16 | NOTICE OF AGM | gsk201003166k.htm |
| 2010-03-16 | 6-K | 2010-03-12 | 6-K | u08522e6vk.htm |
| 2010-03-12 | 6-K | 2010-03-12 | SUCCESSION PLANNING FOR VACCINES BUSINESS | gsk201003126k2.htm |